Loading...
•
Dec 31, 2022
Pediatrix Q4 2022 Earnings Report
Pediatrix reported solid patient volumes, stable payor mix, and reduced overhead, counterbalanced by continuing underperformance by their revenue cycle management vendor.
Key Takeaways
Pediatrix Medical Group reported Q4 2022 results with a net revenue of $514 million, income from continuing operations of $36 million, and Adjusted EBITDA of $66 million. Adjusted EPS from continuing operations was reported at $0.47 per share.
Net revenue for the quarter was $514 million.
Income from continuing operations was $36 million.
Adjusted EBITDA was $66 million.
Adjusted EPS from continuing operations was $0.47.
Forward Guidance
Pediatrix anticipates that its 2023 Adjusted EBITDA will be in a range of $235 million to $245 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...